DS-103

CAT: 0804-HY-173064Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-173064Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

DS-103 is an inhibitor for HDAC that inhibits HDAC1, HDAC2, HDAC3, HDAC6 and HDAC8 with IC50s of 0.029, 0.123, 0.022, 0.367 and 9.26 μM, respectively. DS-103 inhibits Plasmodium falciparum 3D7 with IC50 of 5.08 μM. DS-103 exhibits cytotoxicity in cells A2780 and Cal27 with IC50 of 1.48 μM and 1.47 μM, reverses Cisplatin resistance in A2780 and Cal27 with IC50 of 4.62 μM and 2.23 μM. DS-103 exhibits synergistic effect with Cisplatin (HY-17394), enhances Cisplatin-induced apoptosis[1].

UNSPSC

12352005

Target

HDAC; Parasite

Related Pathways

Anti-infection; Cell Cycle/DNA Damage; Epigenetics

Applications

COVID-19-anti-virus

Field of Research

Cancer; Infection

Smiles

O=C(N(CC1=CC=C(C=C1)C(NNCC)=O)CC(NCC2=CC=CC=C2)=O)C3=CC=C(C=C3)N(C)C

Molecular Formula

C28H33N5O3

Molecular Weight

487.59

References & Citations

[1]Stopper D, et al., Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers DS-103 as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties. J Med Chem. 2025 Feb 27;68 (4) :4426-4452.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

HDAC1; HDAC2; HDAC3; HDAC6; HDAC8

Related Products

Catalog	Name
HY-124131-01	DS-437
HY-131182-01	DS-1971a
HY-P991365	DS-1501
HY-116880	DS-2969b
HY-114217	DS-003
HY-144401-01	DS-3801b
HY-152241-01	DS-9300
HY-P991577-01	DS-8895
HY-163839	DS-1093a
HY-120667-01	DS-5272

Alternative Products

Catalog	Name
GTR19249185-01	DS-103
C18240	DS-1001b (DS 1001)
BA7852-50	DS-1001b
BA4837-50	DS-437
BA4774-1	DS-9300
BD181252-01	DS 16570511
T9901A-1690-01	DS-1501
T89077-01	DS-1093a
T36083-01	DS-7423
T31580	DS-2248

DS-103

Related Products

Alternative Products

Popular Products